The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

CHEBI:16224     (2S,3S,4S,5S)-2,3,4,5- tetrahydroxy-6-oxo...

Synonyms: AR-1I6828, AC1L30YI, AC1Q6A5G, A837154, 6814-36-4, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of D-Mannuronate

  • The alginate capsule produced by the human pathogen Pseudomonas aeruginosa is composed mainly of mannuronic acid polymers (poly-M) that have immunostimulating properties [1].
  • Alginate (Alg), a random polymer of mannuronic acid and glucuronic acid residues, is synthesized and secreted by Pseudomonas aeruginosa primarily during its infection of the lungs of cystic fibrosis patients [2].
  • The effects of alginate composition on cell growth as well as the metabolic and secretory profile of transformed beta-cells entrapped in alginate/poly-L-lysine/alginate (APA) solid beads were investigated following entrapment of beta TC3 mouse insulinoma cells in alginate composed of either high mannuronic acid or high guluronic acid residues [3].
 

High impact information on D-Mannuronate

  • We have determined that key factors responsible for these past failures include cytokine (interleukins 1 and 6 and tumor necrosis factor) stimulation by mannuronic acid monomers from alginate capsules with weak mechanical integrity, which results in fibroblast proliferation [4].
  • Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers [1].
  • Involvement of CD14 and beta2-integrins in activating cells with soluble and particulate lipopolysaccharides and mannuronic acid polymers [5].
  • Induction of tumor necrosis factor production from monocytes stimulated with mannuronic acid polymers and involvement of lipopolysaccharide-binding protein, CD14, and bactericidal/permeability-increasing factor [6].
  • The biological properties of MEP were also shown to be dependent on the structural integrity of the O-acetyl groups substituted for the mannuronic acid residues [7].
 

Biological context of D-Mannuronate

 

Anatomical context of D-Mannuronate

 

Associations of D-Mannuronate with other chemical compounds

  • Cell growth in high guluronic acid alginate took place at random locations throughout the solid bead and not in the periphery, as was the case in high mannuronic acid alginate preparations [3].
  • Capsules with an inhomogeneous solid gel core were made of alginates with high guluronic or high mannuronic acid content and poly-L (PLL)- or poly-D-lysine (PDL) of concentrations varied from 0.05-0.2% [15].
 

Gene context of D-Mannuronate

  • An algG-deletion mutant was constructed and found to produce predominantly a dimer containing a 4-deoxy-L-erythro-hex-4-enepyranosyluronate residue at the nonreducing end and a mannuronic acid residue at the reducing end [16].
  • The authors earlier demonstrated that alginates enriched in mannuronic acid stimulate human monocytes to produce high levels of cytokines such as tumour necrosis factor (TNF), IL-1 IL-6 [17].
  • In the present study, we demonstrate that high mannuronic acid-containing alginate (HMA) inhibits gammaIR induced expression of ICAM-1, VCAM-1, and E-selectin on HUVEC in a dose dependent manner [18].
 

Analytical, diagnostic and therapeutic context of D-Mannuronate

References

  1. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. Flo, T.H., Ryan, L., Latz, E., Takeuchi, O., Monks, B.G., Lien, E., Halaas, Ø., Akira, S., Skjåk-Braek, G., Golenbock, D.T., Espevik, T. J. Biol. Chem. (2002) [Pubmed]
  2. Nucleotide sequence and expression of the algE gene involved in alginate biosynthesis by Pseudomonas aeruginosa. Chu, L., May, T.B., Chakrabarty, A.M., Misra, T.K. Gene (1991) [Pubmed]
  3. Effects of alginate composition on the metabolic, secretory, and growth characteristics of entrapped beta TC3 mouse insulinoma cells. Constantinidis, I., Rask, I., Long, R.C., Sambanis, A. Biomaterials (1999) [Pubmed]
  4. Long-term reversal of diabetes by the injection of immunoprotected islets. Soon-Shiong, P., Feldman, E., Nelson, R., Heintz, R., Yao, Q., Yao, Z., Zheng, T., Merideth, N., Skjak-Braek, G., Espevik, T. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  5. Involvement of CD14 and beta2-integrins in activating cells with soluble and particulate lipopolysaccharides and mannuronic acid polymers. Flo, T.H., Ryan, L., Kilaas, L., Skjâk-Braek, G., Ingalls, R.R., Sundan, A., Golenbock, D.T., Espevik, T. Infect. Immun. (2000) [Pubmed]
  6. Induction of tumor necrosis factor production from monocytes stimulated with mannuronic acid polymers and involvement of lipopolysaccharide-binding protein, CD14, and bactericidal/permeability-increasing factor. Jahr, T.G., Ryan, L., Sundan, A., Lichenstein, H.S., Skjåk-Braek, G., Espevik, T. Infect. Immun. (1997) [Pubmed]
  7. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments. Mai, G.T., Seow, W.K., Pier, G.B., McCormack, J.G., Thong, Y.H. Infect. Immun. (1993) [Pubmed]
  8. Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis. Pedersen, S.S., Espersen, F., Høiby, N., Shand, G.H. J. Clin. Microbiol. (1989) [Pubmed]
  9. The effects of alginate composition on encapsulated betaTC3 cells. Stabler, C., Wilks, K., Sambanis, A., Constantinidis, I. Biomaterials (2001) [Pubmed]
  10. A study of the reaction catalysed by alginate lyase VI from the sea mollusc, Littorina sp. Favorov, V.V., Vozhova, E.I., Denisenko, V.A., Elyakova, L.A. Biochim. Biophys. Acta (1979) [Pubmed]
  11. Stimulation of various functions in murine peritoneal macrophages by high mannuronic acid-containing alginate (HMA) exposure in vivo. Son, E.H., Moon, E.Y., Rhee, D.K., Pyo, S. Int. Immunopharmacol. (2001) [Pubmed]
  12. Immunomodulatory function of murine NK cell activity by alginate. Son, E.W., Yang, K.H., Rhee, D.K., Pyo, S. Arch. Pharm. Res. (2005) [Pubmed]
  13. A study of the effect of capsule composition on the viability of cultured alginate/poly-l-lysine--encapsulated rat islets. Clayton, H.A., London, N.J., Colloby, P.S., Bell, P.R., James, R.F. Diabetes Res. (1990) [Pubmed]
  14. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules. Clayton, H.A., London, N.J., Colloby, P.S., Bell, P.R., James, R.F. Journal of microencapsulation. (1991) [Pubmed]
  15. Alginate polylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulins over the capsule membrane. Kulseng, B., Thu, B., Espevik, T., Skjåk-Braek, G. Cell transplantation. (1997) [Pubmed]
  16. The Pseudomonas fluorescens AlgG protein, but not its mannuronan C-5-epimerase activity, is needed for alginate polymer formation. Gimmestad, M., Sletta, H., Ertesvåg, H., Bakkevig, K., Jain, S., Suh, S.J., Skjåk-Braek, G., Ellingsen, T.E., Ohman, D.E., Valla, S. J. Bacteriol. (2003) [Pubmed]
  17. TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide. Kulseng, B., Skjåk-Braek, G., Følling, I., Espevik, T. Scand. J. Immunol. (1996) [Pubmed]
  18. Inhibition of gamma-irradiation induced adhesion molecules and NO production by alginate in human endothelial cells. Son, E.W., Cho, C.K., Rhee, D.K., Pyo, S. Arch. Pharm. Res. (2001) [Pubmed]
  19. Biocompatibility of mannuronic acid-rich alginates. Klöck, G., Pfeffermann, A., Ryser, C., Gröhn, P., Kuttler, B., Hahn, H.J., Zimmermann, U. Biomaterials (1997) [Pubmed]
  20. Catalytic properties and specificity of a recombinant, overexpressed D-mannuronate lyase. Chavagnat, F., Heyraud, A., Colin-Morel, P., Guinand, M., Wallach, J. Carbohydr. Res. (1998) [Pubmed]
  21. Characterization of the block structure and molecular weight of sodium alginates. Johnson, F.A., Craig, D.Q., Mercer, A.D. J. Pharm. Pharmacol. (1997) [Pubmed]
  22. Effect of viscous injectable pure alginate sol on cultured fibroblasts. Nagakura, T., Hirata, H., Tsujii, M., Sugimoto, T., Miyamoto, K., Horiuchi, T., Nagao, M., Nakashima, T., Uchida, A. Plast. Reconstr. Surg. (2005) [Pubmed]
 
WikiGenes - Universities